Biogetica and Wockhardt Foundation have come together to conduct multidisciplinary research into remedies and strategies to effectively combat the Novel Corona Virus. The research to develop the remedy is being conducted under Corival Life Sciences which boasts of a one of its kind partnership between global leaders in the field of Natural & Pharmaceutical Medicines.
Corival Life Sciences has conducted reviews of published ‘in vivo’, ‘in vitro’ and ‘in silica’ research on Covid 19 basis which their first product called ‘Immunofree’ was launched. ‘Immunofree’ is now being entered into a pharma control trial along with reginmune, a product made by Biogetica that has already shown results in herpes trials.
The USP of the Corival Life Sciences protocol apart from all others is the fact that it combines evidence based nutraceuticals and potent full spectrum herbal extracts, into easy to use pills that synergistically work in multifaceted ways, during these unprecedented times.
This protocol combines learnings from Allopathy, Ayurveda, TCM and Vibrational therapies. It not only boosts immunity but also potentially works on organ protection, docking, inflammation, coagulopathy and bronchodilation. It contains vitamins, minerals, rare amino acids and 18 plants from across the globe that are supported by the latest 2020 research.
Furthermore, These products are a result of the great ancient sciences and biogetica’s various viral and bioavailability patents. ‘Immunofree’ blends a wide variety of phytochemicals, such as alkaloids, polyphenols, flavonoids, saponins, terpenoids, lignans, Xantones, etc.
The Plants chosen for its constitution include those that potentially dissolve viral envelopes, dock into the virus, boost immunity and protect the organs. Hence ‘Immunofree’ serves as a multifaceted solution to the issues prevalent today. This is a one of kind partnership between pharmaceutical and herbal medicine providers and it has yielded a specific multifaceted formula for this unprecedented time.
Trials are being conducted by Firm MGCTS that has prior experience of managing over 100 clinical trials . The trial has already received approvals from Institutional ethics committees from Govt. Medical College and Govt. General Hospital (Old RIMSGGH), Srikakulam; Lokmanya Hospital, Pune; Parul Institute of Ayurveda and Research Parul University; Vadodara and Abhinav Multispeciality hospital, Nagpur.
Apurve Mehra Founder of Biogetica stated, “Herbs included in ‘Immunofree’ have been mandated in China and Madagascar. We hope that by August India proudly announces that it has found an effective way to curtail Novel Coronavirus based on its Ancient Traditional Medicines being proven once again by the new Sciences. Any Drug or Safe Vaccine will take much much longer. We are doing all we can to save lives and livelihoods”
Dr. Huzaifa Khorakiwala CEO of Wockhardt Foundation added “As long as people are healed and lives are saved it doesn’t matter what tradition the remedies come from. Hence we are grateful to offer ‘Immunofree’ to all, across the globe. We will do our best to never deny a human from receiving medicines sprouted by the earth”
Once the Indian and United States clinical trial registries have reviewed ‘Immunofree’ study, it will be ready for recruitment. Corival Life Sciences is looking to do a multicenter, open label, pharma control trial where ‘Immunofree’ will go head to head against Government SOPS of currently used conventional medicines for Covid 19. This trial is unique as it is not an adjunct trial, nor a preventative one, it is one where the main medicine comes from Ayurveda.
